Get the Stockscreener App
1.39
2.96%
0.04
Mira Pharmaceuticals Inc stock is traded at $1.39, with a volume of 279.32K.
It is up +2.96% in the last 24 hours and down -4.14% over the past month.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.
See More
Previous Close:
$1.35
Open:
$1.33
24h Volume:
279.32K
Relative Volume:
0.10
Market Cap:
$58.21M
Revenue:
-
Net Income/Loss:
$-11.24M
P/E Ratio:
-1.8253
EPS:
-0.7615
Net Cash Flow:
$-4.79M
1W Performance:
+0.72%
1M Performance:
-4.14%
6M Performance:
+14.88%
1Y Performance:
+10.32%
1-Day Range:
$1.33
$1.425
1-Week Range:
$1.31
$1.4602
52-Week Range:
$0.73
$2.45
Mira Pharmaceuticals Inc Stock (MIRA) Company Profile
Name
Mira Pharmaceuticals Inc
Sector
Industry
Phone
813-369-5150
Address
1200 BRICKELL AVENUE, MIAMI
Compare MIRA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MIRA
Mira Pharmaceuticals Inc
|
1.39 | 28.11M | 0 | -11.24M | -4.79M | -0.7615 |
|
LLY
Lilly Eli Co
|
1,059.70 | 933.76B | 59.42B | 18.41B | 6.44B | 20.22 |
|
JNJ
Johnson Johnson
|
203.90 | 489.26B | 92.15B | 25.12B | 20.46B | 10.36 |
|
ABBV
Abbvie Inc
|
236.28 | 405.53B | 59.64B | 2.36B | 19.68B | 1.3253 |
|
NVS
Novartis Ag Adr
|
127.31 | 238.62B | 54.45B | 14.42B | 17.15B | 7.333 |
|
MRK
Merck Co Inc
|
97.76 | 235.72B | 63.90B | 19.05B | 13.05B | 7.5596 |
Mira Pharmaceuticals Inc Stock (MIRA) Latest News
MIRA Pharmaceuticals Inc. (MIRA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
What risks investors should watch in MIRA Pharmaceuticals Inc. stockQuarterly Earnings Report & Real-Time Volume Analysis - newser.com
Will MIRA Pharmaceuticals Inc. stock see PE expansionProfit Target & Trade Opportunity Analysis - newser.com
What high frequency data says about MIRA Pharmaceuticals Inc.Weekly Market Outlook & Fast Exit and Entry Trade Guides - newser.com
Why MIRA Pharmaceuticals Inc. stock is favored by pension funds2025 Historical Comparison & Fast Gain Stock Trading Tips - newser.com
Is MIRA Pharmaceuticals Inc. stock trading near support levelsJuly 2025 Catalysts & Verified Momentum Stock Ideas - newser.com
Will MIRA Pharmaceuticals Inc. stock maintain growth storyJuly 2025 Momentum & Fast Entry High Yield Stock Tips - newser.com
Is MIRA Pharmaceuticals Inc. showing signs of accumulationMarket Growth Report & Long-Term Capital Growth Ideas - newser.com
Will MIRA Pharmaceuticals Inc. continue its uptrendDip Buying & Smart Allocation Stock Reports - newser.com
Should you wait for a breakout in MIRA Pharmaceuticals Inc.July 2025 PreEarnings & High Accuracy Investment Entry Signals - newser.com
Will MIRA Pharmaceuticals Inc. stock benefit from sector rotation2025 Technical Patterns & Free Expert Approved Momentum Trade Ideas - newser.com
Applying big data sentiment scoring on MIRA Pharmaceuticals Inc.Earnings Miss & Long-Term Growth Stock Strategies - newser.com
What earnings revisions data tells us about MIRA Pharmaceuticals Inc.2025 Trading Recap & Fast Exit and Entry Strategy Plans - newser.com
Using R and stats models for MIRA Pharmaceuticals Inc. forecasting2025 Retail Activity & Low Drawdown Investment Strategies - newser.com
Is MIRA Pharmaceuticals Inc. forming a bottoming baseLong Setup & Fast Entry and Exit Trade Plans - newser.com
MIRA Pharmaceuticals Announces Oral Mira-55 Outperformed Injected Morphine in Normalizing Pain and Reducing Inflammation, Supporting Its Planned IND for Chronic Inflammatory Pain - Barnstable Patriot
Mira Pharmaceuticals Inc Stock (MIRA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.51%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):